Idera Pharmaceuticals (IDRA)

Add to Watchlists
Create an Alert
3.29 -0.02  -0.60% NASDAQ Apr 24, 8:00PM BATS Real time Currency in USD
View Full Chart
IDRA Price Chart
View All Events

IDRA Events

Date Type Description
Mar 13 Misc Q4 2013 Idera Pharmaceuticals, Inc. Earnings Conference Call
Mar 13 Earnings Q4 2013 Idera Pharmaceuticals, Inc. Earnings Results. Estimate: -0.08.
Nov 14 Misc Q3 2013 Idera Pharmaceuticals, Inc. Earnings Conference Call
Nov 14 Earnings Q3 2013 Idera Pharmaceuticals, Inc. Earnings.
Aug 15 Earnings Idera Pharmaceuticals Reports Second Quarter 2013 Financial Results and Corporate Highlights. Estimate: -0.20.
Jul 26 Misc AGM Event for Idera Pharmaceuticals, Inc.
May 15 Earnings Idera Pharmaceuticals Reports First Quarter 2013 Financial Results. Estimate: -0.19.
View All Performance Charts

IDRA Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Idera Pharmaceuticals is up 408.7% over the last year vs S&P 500 Total Return up 21.54%, Alkermes up 45.95%, and Actelion up 67.22%.

Get Quote for
Advertisement

Portfolio Strategies Featuring IDRA

Did Idera Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

IDRA Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: Massachusetts
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Biological Product (except Diagnostic) Manufacturing
  • NAICS Code: 325414
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Idera Pharmaceuticals, Inc. is a clinical stage biotechnology company engaged in the discovery and development of novel synthetic DNA- and RNA- based drug candidates.

Recent Quotes

Symbol Price Chg Chg % Market Cap
IDRA 3.29 -0.02 -0.60% 244.22M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.